131 related articles for article (PubMed ID: 7594321)
21. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
Miwa H; Yamada T; Sato K; Ohta K; Ohkura R; Murai T; Nagahara A; Takei Y; Ogihara T; Sato N
Dig Dis Sci; 2000 Jan; 45(1):77-82. PubMed ID: 10695617
[TBL] [Abstract][Full Text] [Related]
22. Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide.
Hahm KB; Lee KJ; Kim YS; Kim JH; Cho SW; Yim H; Joo HJ
Dig Dis Sci; 1998 Feb; 43(2):235-40. PubMed ID: 9512112
[TBL] [Abstract][Full Text] [Related]
23. Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.
Feng LY; Yao XX; Jiang SL
World J Gastroenterol; 2005 Feb; 11(7):1083-6. PubMed ID: 15742421
[TBL] [Abstract][Full Text] [Related]
24. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
Schütze K; Hentschel E
Z Gastroenterol; 1995 Nov; 33(11):651-3. PubMed ID: 8600661
[TBL] [Abstract][Full Text] [Related]
25. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
Lüth S; Teyssen S; Kölbel CB; Singer MV
Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
[TBL] [Abstract][Full Text] [Related]
26. [Eradication therapies for Helicobacter pylori].
Hashimoto Y
Kansenshogaku Zasshi; 1998 Jun; 72(6):654-5. PubMed ID: 9695480
[No Abstract] [Full Text] [Related]
27. Efficacy of lansoprazole and amoxicillin in eradicating Helicobacter pylori: evaluation using 13C-UBT and Monoclonal H. pylori antibody testing.
Nakata H; Itoh H; Nishioka S
J Clin Gastroenterol; 1995; 20 Suppl 2():S118-20. PubMed ID: 7594326
[TBL] [Abstract][Full Text] [Related]
28. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N
Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311
[TBL] [Abstract][Full Text] [Related]
29. Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients.
Fukuda Y; Yamamoto I; Okui M; Tonokatsu Y; Shimoyama T
J Clin Gastroenterol; 1995; 20 Suppl 2():S132-5. PubMed ID: 7594330
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
Lamouliatte H; Perie F; Joubert-Collin M
Gastroenterol Clin Biol; 2000 May; 24(5):495-500. PubMed ID: 10891736
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis.
Bazzoli F; Pozzato P; Zagari M; Fossi S; Ricciardiello L; Nicolini G; Berretti D; De Luca L
Helicobacter; 1998 Sep; 3(3):195-201. PubMed ID: 9731991
[TBL] [Abstract][Full Text] [Related]
32. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
[TBL] [Abstract][Full Text] [Related]
33. The effects of nocturnal acid breakthrough on Helicobacter pylori eradication.
Kim JI; Park SH; Kim JK; Chung IS; Chung KW; Sun HS
Helicobacter; 2002 Dec; 7(6):331-6. PubMed ID: 12485118
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
Niv Y
Dig Dis Sci; 2005 May; 50(5):839-41. PubMed ID: 15906754
[TBL] [Abstract][Full Text] [Related]
35. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
Lamouliatte H; Cayla R; Zerbib F; Forestier S; de Mascarel A; Joubert-Collin M; Mégraud F
Am J Gastroenterol; 1998 Sep; 93(9):1531-4. PubMed ID: 9732938
[TBL] [Abstract][Full Text] [Related]
36. Comparison of two lansoprazole-antibiotic combinations (amoxycillin or classical triple therapy) for treatment of H. pylori infection in duodenal ulcer patients.
Parente F; Maconi G; Bargiggia S; Colombo E; Bianchi Porro G
Aliment Pharmacol Ther; 1996 Apr; 10(2):211-3. PubMed ID: 8730253
[TBL] [Abstract][Full Text] [Related]
37. Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.
Lai YC; Wang TH; Huang SH; Yang SS; Wu CH; Chen TK; Lee CL
World J Gastroenterol; 2003 Jul; 9(7):1537-40. PubMed ID: 12854158
[TBL] [Abstract][Full Text] [Related]
38. Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
Ogoshi K; Kato T; Sakagawa T
J Clin Gastroenterol; 1995; 20 Suppl 2():S97-9. PubMed ID: 7594354
[TBL] [Abstract][Full Text] [Related]
39. Treating Helicobacter pylori.
Howden CW; Hunt RH
Arch Intern Med; 1998 Nov; 158(21):2396-8. PubMed ID: 9827792
[No Abstract] [Full Text] [Related]
40. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]